Use of medication during pregnancy and risk of childhood leukemia (Canada)

Cancer Causes Control. 2004 Nov;15(9):931-7. doi: 10.1007/s10552-004-2230-6.

Abstract

Objective: To examine risk of childhood acute lymphoblastic leukemia (ALL) associated with maternal use of medications during pregnancy; in particular medications known or suspected to be teratogenic.

Methods: Seven hundred and eighty nine children (< 15 years old) diagnosed with ALL in the province of Quebec between 1980 and 2000 were recruited for study. A similar number of population based controls matched to cases (1:1) by sex and age were chosen from family allowance or health insurance files. Information was gathered via telephone interview with the subjects' parents. Data were analyzed using conditional logistic regression.

Results: Risk of childhood ALL was significantly increased in the offspring of mothers who reported using any medication (adjusted odds ratio (OR(adj)) = 1.3, 95% CI = 1.0-1.6) or any teratogenic medication (OR(adj) = 1.4, 95% CI = 1.1-1.9) during pregnancy. Among specific medication categories, only central nervous system depressants were associated with a significantly increased risk, although elevated odd ratios were found for anti-epileptics, immunosuppressants, oral contraceptives, and illicit drugs. Risk associated with use of teratogenic medications was higher with increased dose and in children diagnosed before two years of age.

Conclusion: A modest increase in risk of ALL was found among children of mothers who used medication during pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Canada / epidemiology
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug-Related Side Effects and Adverse Reactions*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Interviews as Topic
  • Male
  • Maternal Exposure / adverse effects*
  • Pharmaceutical Preparations / administration & dosage
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / chemically induced*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology*
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Risk Factors
  • Teratogens

Substances

  • Pharmaceutical Preparations
  • Teratogens